Assistant Professor

Daniel Beriault

Department of Laboratory Medicine & Pathobiology


St. Michael’s Hospital: Unity Health Toronto
30 Bond St., Toronto, Ontario Canada M5B 1W8
Research Interests
Metabolism & Nutrition, Molecular & Cell Biology
Clinical Interests
Clinical Chemistry
Appointment Status

Dr. Daniel Beriault is a fellow of the Canadian Academy of Clinical Biochemists (FCACB) and the Head of Biochemistry at Unity Health Toronto.

He completed his PhD in Biochemistry at McMaster University and the post-doctoral clinical biochemistry training at the University of Toronto.

Daniel has a particular interest in lab utilization, endocrinology and toxicology.

Dr. Beriault is on:

  1. LinkedIn
  2. Twitter @BeriaultDan

Selected Publications

Mohammed-Ali, Z. Delaney, SR. Singh, R. Leung, F. Taher, J. Goguen, J. Gilmour, J. Sepiashvili, L. Beriault, DR. Bias in IGF-1 concentrations and interpretation across three different clinical laboratory assays. Clinical Biochemistry. 2022: doi: 10.1016/j.clinbiochem.2022.06.009.

Scarfone, K. Maghsoudi, N. McDonald, K. Thompson, H. Stefan, C. Beriault, DR. Werb, D. Bowles, JM. Emerging synthetic cannabinoids detected by a Drug Checking Service in Toronto, Canada. Clinical Toxicology. 2022: May 12:1-6. doi: 10.1080/15563650.2022.2069575.

White-Al Habeeb, N. Higgins, V. Venner, AA. Bailey, D. Beriault, DR. Collier, C. Adeli, K. on behalf of the Canadian Society of Clinical Chemists (CSCC) Working Group on Reference Interval Harmonization. Harmonized lipid reporting for clinical laboratories based on the 2021 Canadian Lipids Guidelines. Canadian Journal of Cardiology. 2022: doi: 10.1016/j.cjca.2022.03.019. 

Higgins, V. Kapur, BM. Beriault, DR. Delaney, S. Perplexingly high tacrolimus concentrations in a renal transplant patient with HIV. Clinical Chemistry. 2022: doi: 10.1093/clinchem/hvac062.

Scarfone, K. Maghsoudi, N. McDonald, K. Stefan, C. Beriault, DR. et al. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada October 2019-April 2020. Harm Reduction Journal. 2022:

Higgins, V. Leiter, LA. Delaney, SR. Beriault, DR. Validating the NIH LDL-C equation in a specialized lipid cohort: Does it add up? Clinical Biochemistry. 2021: doi: 10.1016/j.clinbiochem.2021.10.003. 

Bowles, JM. McDonald, K. Maghsoudi, N. Thompson, H. Stefan, C. Beriault, DR. Delaney, S. Wong, E. Werb, D. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Harm Reduction Journal. 2021: 

Mohammed-Ali, Z. Beriault DR. How do you use quality improvement methods to reduce unnecessary free thyroid hormone testing? AACC Academy Scientific Shorts. July 2021.

Higgins, V. Delaney, S. Beriault, DR. Pushing the new NIH LDL-C equation to its limits. Journal of Applied Laboratory Medicine. 2021:

Mohammad-Ali, Z. Bhandarkar, S. Tahir, S. Handford, C. Yip, D. Beriault, DR.* Hicks, LK.* Implementing effective test utilization via team-based evaluation and revision of a family medicine laboratory test requisition. BMJ Open Qual. 2021: doi: 10.1136/bmjoq-2020-001219.

Parker, ML. Sholzberg, M. Yip, PM. Beriault, DR. The problem with population data for the determination of ferritin lower reference interval limits. Clinical Biochemistry. 2021: doi: 10.1016/j.clinbiochem.2021.03.013.

Beriault, DR. Gilmour, JA. Hicks, LK. Overutilization in laboratory medicine: tackling the problem with quality improvement science. Crit Rev Clin Lab Sci. 2021: doi: 10.1080/10408363.2021.1893642.

Ti, L. Tobias, S. Maghsoudi, N. Milloy, M-J. McDonald, K. Shapiro, A. Beriault, D. Stefan, C. Lysyshyn, M. Werb, D. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings. Drug and Alcohol Review. 2020. doi: 10.1111/dar.13237.

Parker, ML. Storm, S. Sholzberg, M. Yip, PM. Beriault, DR. Revising ferritin lower limits: It’s time to raise the bar on iron deficiency. Journal of Applied Laboratory Medicine. 2020:

Higgins, V. Patel, K. Kulasingam, V. Beriault, DR. Rutledge, AC. Selvaratnam, R. Analytical performance evaluation of thyroid-stimulating hormone receptor antibody (TRAb) immunoassays. Clinical Biochemistry. 2020: 10.1016/j.clinbiochem.2020.08.007.

Taher, J*. Beriault, DR*. Yip, D. Tahir, S. Hicks, LK. and Gilmour, JA. Reducing free thyroid hormone testing through multiple Plan-Do-Study-Act cycles. Clinical Biochemistry. 2020: 

Langford, BJ.* Beriault, D.* Schwartz, KL. Seah, J. Pasic, MD. Cirone, R. Chan, A. and Downing, M. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU. Journal of Critical Care. 2020:

Young, A. Beriault, D. Jung, B. Nikonova, A. Abosh, D. Lee, S. Zaltzman, J. and Perl, J. DAMPAned Methotrexate: A case report and review of the management of acute methotrexate toxicity. CJKHD. 2019: 10.1177/2054358119895078.

Maghsoudi N, McDonald K, Stefan C, Beriault DR, et al. Evaluating networked drug checking services in Toronto, Ontario: Study Protocol and Rationale. Harm Reduction Journal. 2019: 10.1186/s12954-019-0336-0

Taher, J. Brinc, D. Gilmour, J. and Beriault, DR. Validating thyroid stimulating hormone (TSH) reflexive testing cutpoints in a tertiary care institution. Clinical Chemistry Laboratory Medicine. 2019: 10.1515/cclm-2019-0396.

Fung, A.* Beriault, D.* Diamandis, E.P. Burnham, C. Dorman, T. Downing, M. Hayden, J. and Langford, B. The role of procalcitonin in diagnosis of sepsis and antimicrobial stewardship: opportunities and challenges. Clinical Chemistry. 2017: clinchem.2017.272294.